X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (17) 17
index medicus (17) 17
humans (16) 16
atrophic vaginitis (12) 12
middle aged (8) 8
obstetrics & gynecology (8) 8
atrophic vaginitis - physiopathology (7) 7
menopause (7) 7
postmenopausal women (7) 7
abridged index medicus (6) 6
estrogen (6) 6
aged (5) 5
atrophy (5) 5
postmenopause (5) 5
quality of life (5) 5
vagina - pathology (5) 5
adult (4) 4
atrophic vaginitis - drug therapy (4) 4
estrogen replacement therapy (4) 4
estrogen therapy (4) 4
vaginal atrophy (4) 4
aging (3) 3
double-blind (3) 3
estrogens - therapeutic use (3) 3
female urogenital diseases - physiopathology (3) 3
low-dose estradiol (3) 3
menopause - physiology (3) 3
obstetrics and gynecology (3) 3
quality-of-life (3) 3
severity of illness index (3) 3
treatment outcome (3) 3
urogenital atrophy (3) 3
vagina - physiopathology (3) 3
vaginal creams, foams, and jellies - therapeutic use (3) 3
vaginal dryness (3) 3
vaginitis - drug therapy (3) 3
vaginitis - etiology (3) 3
administration, intravaginal (2) 2
age factors (2) 2
aging - physiology (2) 2
atrophic vaginitis - complications (2) 2
atrophic vaginitis - diagnosis (2) 2
atrophic vaginitis - etiology (2) 2
atrophic vaginitis - therapy (2) 2
breast neoplasms - complications (2) 2
dehydroepiandrosterone - therapeutic use (2) 2
development and progression (2) 2
diseases (2) 2
dyspareunia (2) 2
dyspareunia - physiopathology (2) 2
dyspareunia - therapy (2) 2
estriol (2) 2
estriol - adverse effects (2) 2
estriol - therapeutic use (2) 2
estrogen replacement therapy - adverse effects (2) 2
estrogens - physiology (2) 2
genitourinary syndrome of menopause (2) 2
health aspects (2) 2
hormone replacement therapy (2) 2
hormone therapy (2) 2
hormone-replacement therapy (2) 2
hot flashes (2) 2
hot flashes - etiology (2) 2
hot flashes - therapy (2) 2
hyaluronic acid (2) 2
hyaluronic acid - adverse effects (2) 2
hydrogen-ion concentration (2) 2
life style (2) 2
lubricants - therapeutic use (2) 2
medicine, general & internal (2) 2
multicenter (2) 2
nursing (2) 2
perimenopause (2) 2
pregnancy (2) 2
randomized controlled-trial (2) 2
reproductive biology (2) 2
risk factors (2) 2
secondary prevention (2) 2
selective estrogen receptor modulators - therapeutic use (2) 2
sexual disorders (2) 2
syndrome (2) 2
tablets (2) 2
urinary incontinence (2) 2
urinary incontinence - physiopathology (2) 2
urinary tract infections - complications (2) 2
urinary tract infections - microbiology (2) 2
urinary tract infections - prevention & control (2) 2
vagina - drug effects (2) 2
vaginitis - diagnosis (2) 2
vaginitis - pathology (2) 2
vaginitis - physiopathology (2) 2
vasomotor symptoms (2) 2
vulvovaginal atrophy (2) 2
women (2) 2
women's health (2) 2
3-o-beta-d-glucuronide (1) 1
actins - antagonists & inhibitors (1) 1
acupuncture therapy (1) 1
adjuvants, immunologic - therapeutic use (1) 1
administration, cutaneous (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gynecological Endocrinology, ISSN 0951-3590, 02/2018, Volume 34, Issue 2, pp. 140 - 143
Journal Article
Seminars in Oncology Nursing, ISSN 0749-2081, 02/2014, Volume 30, Issue 1, pp. 53 - 60
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 207, pp. 125 - 128
Abstract Objective To assess whether the orally administered combination of hyaluronic acid (HA), chondroitin sulfate (CS), curcumin and quercetin could be... 
Obstetrics and Gynecology | Urinary tract infections | Curcumin | Glycosaminoglycans | Quercetin | Estrogen | MULTICENTER | INTERSTITIAL CYSTITIS | 3-O-BETA-D-GLUCURONIDE | BACTERIAL CYSTITIS | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | THERAPY | MICE | METABOLITE | EXPRESSION | Hyaluronic Acid - therapeutic use | Humans | Middle Aged | Secondary Prevention | Urinary Tract Infections - prevention & control | Vaginal Creams, Foams, and Jellies - adverse effects | Estrogens - adverse effects | Urinary Tract Infections - complications | Estrogens - therapeutic use | Vaginal Creams, Foams, and Jellies - therapeutic use | Chondroitin Sulfates - adverse effects | Anti-Infective Agents, Urinary - adverse effects | Aging | Anti-Infective Agents, Urinary - therapeutic use | Postmenopause | Female | Urinary Tract Infections - microbiology | Dietary Supplements - adverse effects | Hyaluronic Acid - adverse effects | Severity of Illness Index | Atrophic Vaginitis - physiopathology | Curcumin - therapeutic use | Quercetin - therapeutic use | Disease Resistance - drug effects | Curcumin - adverse effects | Chondroitin Sulfates - therapeutic use | Combined Modality Therapy - adverse effects | Atrophic Vaginitis - drug therapy | Estrogen Replacement Therapy - adverse effects | Antioxidants - therapeutic use | Estriol - adverse effects | Quercetin - adverse effects | Antioxidants - adverse effects | Estriol - therapeutic use | Urinary Tract Infections - urine | Atrophic Vaginitis - complications | Prevention | Relapse | Postmenopausal women | Sulfates | Hyaluronic acid | Chondroitin | Diseases | Evaluation | Analysis | Index Medicus
Journal Article
Journal of Family Practice, ISSN 0094-3509, 03/2012, Volume 61, Issue 3, pp. 138 - 145
Let patients know that hot flashes, vaginal dryness, and other common menopausal symptoms can be treated successfully with hormonal and nonhormonal agents. 
ESTROGEN THERAPY | MEDICINE, GENERAL & INTERNAL | PLACEBO | HORMONE-THERAPY | VASOMOTOR SYMPTOMS | BLACK COHOSH | DOUBLE-BLIND | VAGINAL ATROPHY | PHYSICAL-ACTIVITY | PRIMARY HEALTH CARE | POSTMENOPAUSAL WOMEN | HOT FLASHES | Dyspareunia - physiopathology | Life Style | Age Factors | Humans | Middle Aged | Menopause - psychology | Administration, Cutaneous | Hypnotics and Sedatives - therapeutic use | Acupuncture Therapy | Antidepressive Agents, Second-Generation - therapeutic use | Eszopiclone | Affect | Hormone Replacement Therapy | Estrogens - therapeutic use | Libido - drug effects | Dose-Response Relationship, Drug | Minoxidil - therapeutic use | Cyproterone Acetate - therapeutic use | Exercise | Androgens - therapeutic use | Azabicyclo Compounds - therapeutic use | Female | Phytotherapy | Adjuvants, Immunologic - therapeutic use | Spironolactone - therapeutic use | Bupropion - therapeutic use | Testosterone - therapeutic use | Lubricants - therapeutic use | Atrophic Vaginitis - physiopathology | Sleep Initiation and Maintenance Disorders - etiology | Atrophic Vaginitis - therapy | Dehydroepiandrosterone - therapeutic use | Sleep Initiation and Maintenance Disorders - therapy | Piperazines - therapeutic use | Hot Flashes - etiology | Mineralocorticoid Receptor Antagonists - therapeutic use | Antidepressive Agents - therapeutic use | Dyspareunia - therapy | Androgen Antagonists - therapeutic use | Hair - drug effects | Hot Flashes - therapy | Administration, Topical | Menopause - physiology | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 215, Issue 6, pp. 704 - 711
Genitourinary syndrome of menopause, a new term for a condition more renowned as atrophic vaginitis, is a hypoestrogenic condition with external genital,... 
Obstetrics and Gynecology | urogenital atrophy | vulvovaginal atrophy | nonhormonal vaginal therapy | atrophic vaginitis | dyspareunia | quality of life | estrogen-progestin therapy | hypoestrogenism | urinary incontinence | genitourinary syndrome of menopause | menopausal hormone therapy | vaginal maturation index | SELECTIVE ESTROGEN COMPLEX | SEXUAL HEALTH | LASER THERAPY | LASOFOXIFENE | OBSTETRICS & GYNECOLOGY | BONE LOSS | URINARY-TRACT | QUALITY-OF-LIFE | POSTMENOPAUSAL WOMEN | VULVO-VAGINAL ATROPHY | Atrophic Vaginitis - metabolism | Dyspareunia - physiopathology | Life Style | Humans | Menopause | Vulvar Diseases - therapy | Atrophic Vaginitis - diagnosis | Vulvar Diseases - metabolism | Vulvar Diseases - diagnosis | Selective Estrogen Receptor Modulators - therapeutic use | Urinary Incontinence - metabolism | Female | Oxytocics - therapeutic use | Lubricants - therapeutic use | Atrophic Vaginitis - physiopathology | Low-Level Light Therapy - methods | Urinary Incontinence - physiopathology | Urinary Incontinence - diagnosis | Atrophic Vaginitis - therapy | Dehydroepiandrosterone - therapeutic use | Urinary Incontinence - therapy | Syndrome | Dyspareunia - therapy | Estrogen Replacement Therapy - methods | Quality of Life | Vulvar Diseases - physiopathology | Oxytocin - therapeutic use | Dyspareunia - diagnosis | Dyspareunia - metabolism | Medical colleges | Lasers in surgery | Lubrication and lubricants | Estrogen | Development and progression | Postmenopausal women | Diseases | Homeopathy | Materia medica and therapeutics | Lasers in medicine | Dehydroepiandrosterone | Causes and theories of causation | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Nurse Practitioner, ISSN 0361-1817, 01/2011, Volume 36, Issue 1, pp. 22 - 28
Atrophic vaginitis is a common finding in women with low estrogen states. Many women believe their symptoms are expected signs of aging. NPs can provide... 
Atrophy | Nurse Practitioners | Women's Health | Humans | Postmenopause | Female | Treatment Outcome | Vaginitis - pathology | Vaginitis - physiopathology | Education, Nursing, Continuing | Vaginitis - therapy | Care and treatment | Estrogen | Physiological aspects | Development and progression | Diagnosis | Atrophic vaginitis | Health aspects | Index Medicus | Nursing
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2006, Volume 86, Issue 4, pp. 1152 - 1163
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 1991, Volume 165, Issue 4, pp. 1249 - 1254+1227
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.